Southwest Hospital — Chongqing

Public research footprint of Southwest Hospital, compiled from the ClinicalTrials.gov public registry.

271

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC) · Carcinoma, Non-Small-Cell Lung · Chronic Obstructive Pulmonary Disease (COPD) · Advanced Hepatocellular Carcinoma (HCC)

Recently updated registry entries

NCT03748641 — A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus… (Active Not Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT05388669 — A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Southwest Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.